https://www.selleckchem.com/products/U0126.html
8, CI 2.5-13.4, P 0.001] were independent predictors of 4 year RFS ≤ 50%. When AFP was 600 ng/ml, MVI was seen in 88.9% tumors with poor grade and 75% of tumors outside University of California San Francisco criteria. Estimated 4 year RFS was 78% for the entire cohort. When AFP was 600 ng/ml, 4 year RFS for well-moderate and poor grade tumors was 88 and 73%. With AFP 600 ng/ml, RFS was 53% and 0 with well-moderate and poor grade tumors respectively (P 0.001). Patients with AFP 600 ng/ml have acceptable outcomes
Like
Comment
Share
